Table of Contents
Table 5-21: Fayette
Table 5-23: Fountain
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 185 | 589.7 | 972 | 633.5 | 73 | 237.4 | 382 | 260.6 |
| Esophagus | * | # | 13 | 8.7** | * | # | 16 | 11.0** |
| Stomach | 7 | 24.2** | 16 | 11.5** | * | # | 10 | 6.7** |
| Colon excluding Rectum | 13 | 38.3** | 67 | 44.4 | 6 | 22.3** | 32 | 23.6 |
| Rectum and Rectosigmoid Junction | 5 | 16.1** | 31 | 20.3 | * | # | 2 | # |
| Liver | * | # | 9 | 5.4** | * | # | 8 | 4.7** |
| Pancreas | 5 | 18.1** | 19 | 12.1** | 5 | 16.0** | 19 | 11.7** |
| Lung and Bronchus | 26 | 80.9 | 172 | 109.9 | 24 | 76.2 | 138 | 89.4 |
| Melanoma of the Skin | 5 | 13.0** | 29 | 18.2 | * | # | 5 | 3.3** |
| Prostate | 63 | 208.4 | 294 | 199.3 | * | # | 34 | 28.2 |
| Urinary Bladder | 13 | 43.7** | 80 | 52.5 | * | # | 10 | 7.5** |
| Kidney and Renal Pelvis | * | # | 26 | 15.5 | * | # | 6 | 4.2** |
| Brain and Other Nervous System | 5 | 15.2** | 17 | 10.3** | * | # | 9 | 5.5** |
| Non-Hodgkin Lymphoma | 9 | 28.1** | 35 | 21.7 | * | # | 11 | 7.5** |
| Myeloma | 5 | 16.1** | 12 | 8.2** | * | # | 7 | 5.2** |
| Leukemia | 5 | 17.2** | 24 | 15.9 | 5 | 16.2** | 17 | 11.8** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 159 | 381.4 | 877 | 432.6 | 72 | 173.2 | 407 | 197.2 |
| Colon excluding Rectum | 9 | 19.2** | 71 | 33.1 | 6 | 14.8** | 40 | 19.5 |
| Rectum and Rectosigmoid Junction | * | # | 23 | 11.4 | * | # | 5 | 2.4** |
| Liver | * | # | 6 | 2.9** | * | # | 5 | 2.3** |
| Pancreas | 6 | 15.2** | 27 | 12.8 | 5 | 12.2** | 25 | 11.8 |
| Lung and Bronchus | 30 | 73.1 | 154 | 75.6 | 21 | 51.0 | 118 | 57.2 |
| Melanoma of the Skin | 6 | 15.3** | 27 | 14.3 | * | # | 3 | # |
| Breast | 38 | 90.1 | 257 | 128.0 | 11 | 26.8** | 59 | 28.9 |
| Cervix Uteri | 5 | 12.3** | 16 | 8.0** | * | # | 7 | 3.4** |
| Corpus Uteri | 10 | 24.0** | 41 | 20.8 | * | # | 6 | 3.0** |
| Ovary | * | # | 31 | 15.5 | * | # | 24 | 11.9 |
| Urinary Bladder | * | # | 20 | 9.6 | * | # | 8 | 4.0** |
| Kidney and Renal Pelvis | 5 | 11.4** | 26 | 12.6 | * | # | 11 | 5.1** |
| Brain and Other Nervous System | 5 | 12.8** | 12 | 6.2** | * | # | 3 | # |
| Non-Hodgkin Lymphoma | 5 | 11.7** | 28 | 13.2 | * | # | 17 | 8.1** |
| Myeloma | * | # | 6 | 3.0** | * | # | 4 | # |
| Leukemia | 5 | 12.0** | 24 | 12.1 | * | # | 14 | 6.4** |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-21: Fayette
Table 5-23: Fountain
